Brief: Briacell Therapeutics Corp - Regains Compliance With Nasdaq Minimum Bid Price Requirement
13/02/2025 22:18
Briacell Therapeutics Corp BCT.TO :
* BRIACELL THERAPEUTICS CORP - REGAINS COMPLIANCE WITH
NASDAQ
MINIMUM BID PRICE REQUIREMENT
Source text: ID:n0001493152-25-006419
Further company coverage: BCT.TO
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study